Drug intelligence / Profile preview

rifampin + gentamicin

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Oral, Topical
01

Overview

Rifampin + gentamicin is a combination of two long-established antibacterial drugs, rifampin (also known as rifampicin) and gentamicin. Rifampin is a rifamycin-class antibiotic that inhibits bacterial DNA-dependent RNA polymerase, while gentamicin is an aminoglycoside antibiotic that binds to the bacterial 30S ribosomal subunit to inhibit protein synthesis. This combination is historically recommended as an adjunctive regimen alongside a backbone antibiotic (such as oxacillin, nafcillin, cefazolin, or vancomycin) for the treatment of staphylococcal prosthetic valve endocarditis (PVE). It is also utilized as an antimicrobial dip or irrigation solution in surgical procedures, such as inflatable penile prosthesis (IPP) implantations, to prevent postoperative infections. Because both components are widely available as generic medications, no single company is actively developing this combination.

Other names
rifampicin + gentamicinrifampicin and gentamicinrifampin and gentamicin
02

Targets

Bacterial RibosomerpoB (DNA-directed RNA polymerase subunit beta)

Beyond the preview

Go deeper on rifampin + gentamicin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rifampin + gentamicin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call